PipelinePharma Logo

Generics 23

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Artemether manufacturers

23 products found

Filters

Filters

Filters , active

Country of origin : Pakistan

Clear all

23 products found

artemether + lumefantrine

Tablets 40 mg + 240 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Pakistan
GMP approvals
WHO
Manufacturer #20897

This CTD dossier owner and manufacturer is a prominent player in the pharmaceutical industry, specializing in both human and animal health products. Their diverse portfolio includes branded generics, biologics, injectables, personal hygiene items, and consumer products. They boast a state-of-the-art GMP-compliant facility and have established subsidiaries to focus on specific areas like carbapenem injectables and consumer goods. The company is recognized for its commitment to quality, evidenced by certifications such as ISO 9001:2015, ISO 14001:2015, and ISO 45001:2018. They have a strong presence in regions like the EU, North America, Asia, and the Middle East. Key therapeutic areas include infectious diseases and mental health, with principal dosage forms encompassing oral solutions, tablets, injectables, and topical creams. The company actively invests in research and development to bring innovative products to market.

artemether + lumefantrine

Granules for oral suspension 15 mg + 90 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Pakistan
GMP approvals
WHO
Manufacturer #20897

This CTD dossier owner and manufacturer is a prominent player in the pharmaceutical industry, specializing in both human and animal health products. Their diverse portfolio includes branded generics, biologics, injectables, personal hygiene items, and consumer products. They boast a state-of-the-art GMP-compliant facility and have established subsidiaries to focus on specific areas like carbapenem injectables and consumer goods. The company is recognized for its commitment to quality, evidenced by certifications such as ISO 9001:2015, ISO 14001:2015, and ISO 45001:2018. They have a strong presence in regions like the EU, North America, Asia, and the Middle East. Key therapeutic areas include infectious diseases and mental health, with principal dosage forms encompassing oral solutions, tablets, injectables, and topical creams. The company actively invests in research and development to bring innovative products to market.

artemether + lumefantrine

Tablets 40 mg+240 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Pakistan
GMP approvals
United Kingdom
Manufacturer #18910
This pharmaceutical company, established in 1990, is a leader in its region, boasting over 180 registered products marketed both domestically and internationally. Specializing in innovative drug formulations and medicines, the company holds a prestigious MHRA CGMP certification, granting it the authority to market products within the EU and UK. Their production capabilities are extensive, reaching up to 1,000,000 units daily, thanks to advanced machinery imported from Germany, Switzerland, China, and Italy. The company's expertise spans various therapy areas, including (information not provided), utilizing principal dosage forms such as (information not provided). They offer contract manufacturing services to reputable international companies and adhere to strict GMP guidelines, evident in their product patents and registrations with the local regulatory authority (DRAP).

Manufacturer usually replies in 7 days

Want to see all 23 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription
Artemether is a medication used to treat malaria. Although manufacturers of artemether produce drugs with it as the standalone ingredient, it is almost always marketed in combination with lumefantrine. Artemether suppliers market it in the form of oral tablets as well as injectable solutions. The developer and earliest manufacturer of artemether/lumefantrine medications is Novartis, who markets it under the trade name Coartem. The standalone formulation was first introduced into medical use in 1987, whereas the artemether/lumefantrine combination formulation was first approved in 1992. Both drugs have since gained approvals in over 80 countries worldwide, including the U.S., China, numerous African countries and across Europe. What is more, the drug has become included in the World Health Organization’s list of Essential Medicines that contains the most important medications recommended for a basic health system. Alternatives to artemether are other artemisinin class malaria drugs such as dihydroartemisinin and artesunate. The prices of artemether medications are not particularly high. Its wholesale cost in the developing world typically falls into a range of 0,10 EUR to 1,00 EUR per daily treatment dose.

Popular Searches

Amoxicillin manufacturers Atorvastatin manufacturers Benzocaine manufacturers Calcium carbonate manufacturers Cloperastine fendizoate manufacturers Gabapentin manufacturers Hyaluronic acid manufacturers Ibuprofen manufacturers Ivermectin manufacturers Levothyroxine manufacturers Lisinopril manufacturers Losartan manufacturers Magnesium manufacturers Melatonin manufacturers Metformin manufacturers Methotrexate manufacturers Metoprolol manufacturers Omeprazole manufacturers Paracetamol manufacturers Prednisone manufacturers Pregabalin manufacturers Semaglutide manufacturers Testosterone enanthate manufacturers Vitamin B12 manufacturers

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible